These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 39262210)
1. Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder. Brand BA; Sommer IE; Gangadin SS; Tanskanen A; Tiihonen J; Taipale H Am J Psychiatry; 2024 Oct; 181(10):893-900. PubMed ID: 39262210 [TBL] [Abstract][Full Text] [Related]
2. Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse. Sommer IE; Brand BA; Gangadin S; Tanskanen A; Tiihonen J; Taipale H Schizophr Bull; 2023 Jan; 49(1):136-143. PubMed ID: 36198044 [TBL] [Abstract][Full Text] [Related]
3. Real-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study. Taipale H; Tanskanen A; Correll CU; Tiihonen J Lancet Psychiatry; 2022 Apr; 9(4):271-279. PubMed ID: 35182475 [TBL] [Abstract][Full Text] [Related]
4. Effect of menopausal hormonal therapy on cardiovascular risks in Korean postmenopausal women: A nationwide cohort study. Yuk JS; Kim GS; Byun YS; Yang SW; Kim MH; Yoon SH; Seo YS; Kim BG BJOG; 2024 Aug; 131(9):1306-1317. PubMed ID: 38465460 [TBL] [Abstract][Full Text] [Related]
5. Endometrial cancer risk with menopausal hormone therapy: Health Insurance Database in South Korea-based cohort study. Yuk JS Int J Gynaecol Obstet; 2023 Aug; 162(2):502-513. PubMed ID: 36964935 [TBL] [Abstract][Full Text] [Related]
6. Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study. Solmi M; Tiihonen J; Lähteenvuo M; Tanskanen A; Correll CU; Taipale H Schizophr Bull; 2022 Jan; 48(1):166-175. PubMed ID: 34286338 [TBL] [Abstract][Full Text] [Related]
7. Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials. Taipale H; Schneider-Thoma J; Pinzón-Espinosa J; Radua J; Efthimiou O; Vinkers CH; Mittendorfer-Rutz E; Cardoner N; Pintor L; Tanskanen A; Tomlinson A; Fusar-Poli P; Cipriani A; Vieta E; Leucht S; Tiihonen J; Luykx JJ JAMA Psychiatry; 2022 Mar; 79(3):210-218. PubMed ID: 35080618 [TBL] [Abstract][Full Text] [Related]
8. Relationship between menopausal hormone therapy and breast cancer: A nationwide population-based cohort study. Yuk JS Int J Gynaecol Obstet; 2024 Aug; 166(2):735-744. PubMed ID: 38469634 [TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study. Yuk JS; Kim T; Cho H; Gwak G Eur J Endocrinol; 2024 Jan; 190(1):1-11. PubMed ID: 38128117 [TBL] [Abstract][Full Text] [Related]
10. Real-world effectiveness of antidepressants, antipsychotics and their combinations in the maintenance treatment of psychotic depression. Evidence from within-subject analyses of two nationwide cohorts. Taipale H; Lieslehto J; Lähteenvuo M; Hamina A; Tanskanen A; Mittendorfer-Rutz E; Paljärvi T; Solmi M; Cipriani A; Correll CU; Tiihonen J World Psychiatry; 2024 Jun; 23(2):276-284. PubMed ID: 38727044 [TBL] [Abstract][Full Text] [Related]
11. Menopausal hormone therapy and risk of incident hypertension: role of the route of estrogen administration and progestogens in the E3N cohort. Madika AL; MacDonald CJ; Fournier A; Mounier-Vehier C; Béraud G; Boutron-Ruault MC Menopause; 2021 Sep; 28(11):1204-1208. PubMed ID: 34581294 [TBL] [Abstract][Full Text] [Related]
12. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia. Tiihonen J; Mittendorfer-Rutz E; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Taipale H JAMA Psychiatry; 2017 Jul; 74(7):686-693. PubMed ID: 28593216 [TBL] [Abstract][Full Text] [Related]
13. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause. Davey DA Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis. Solmi M; Taipale H; Holm M; Tanskanen A; Mittendorfer-Rutz E; Correll CU; Tiihonen J Am J Psychiatry; 2022 Dec; 179(12):938-946. PubMed ID: 36200276 [TBL] [Abstract][Full Text] [Related]
15. Menopause, hysterectomy, menopausal hormone therapy and cause-specific mortality: cohort study of UK Biobank participants. Xu Z; Chung HF; Dobson AJ; Wilson LF; Hickey M; Mishra GD Hum Reprod; 2022 Aug; 37(9):2175-2185. PubMed ID: 35690930 [TBL] [Abstract][Full Text] [Related]
16. Menopausal hormone therapy and risk of dementia: health insurance database in South Korea-based retrospective cohort study. Yuk JS; Lee JS; Park JH Front Aging Neurosci; 2023; 15():1213481. PubMed ID: 37744387 [TBL] [Abstract][Full Text] [Related]
17. Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts. Lähteenvuo M; Luykx JJ; Taipale H; Mittendorfer-Rutz E; Tanskanen A; Batalla A; Tiihonen J Br J Psychiatry; 2022 Dec; 221(6):758-765. PubMed ID: 36004532 [TBL] [Abstract][Full Text] [Related]
18. Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea-based retrospective cohort study. Yuk JS; Kim JM Menopause; 2023 May; 30(5):497-505. PubMed ID: 36917757 [TBL] [Abstract][Full Text] [Related]
19. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study. Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686 [TBL] [Abstract][Full Text] [Related]
20. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Robinson D; Woerner MG; Alvir JM; Bilder R; Goldman R; Geisler S; Koreen A; Sheitman B; Chakos M; Mayerhoff D; Lieberman JA Arch Gen Psychiatry; 1999 Mar; 56(3):241-7. PubMed ID: 10078501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]